Comprehensive Management for the Treatment of Obstructive Sleep Apnea
NCT ID: NCT02482480
Last Updated: 2016-03-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
27 participants
INTERVENTIONAL
2014-10-31
2015-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effectiveness of an Intensive Weight Loss Program for Obstructive Sleep Apnea Syndrome (OSAS) Treatment.
NCT02832414
OBese Patients With Obstructive Sleep Apnea Syndrome(OSAS) and EXercise Training
NCT01155271
Continuous Positive Airway Pressure (CPAP), Oral Appliance and Physical Exercise in the Obstructive Sleep Apnea
NCT01289392
Effects of an Individualized Training Program on Severity Markers of Obstructives Sleep Apnea/Hypopnea Syndrome (OSAS)
NCT01256307
Effects of Exercise on Obstructive Sleep Apnea Severity in Elderly
NCT04120428
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Physical exercise has been shown to ameliorate the consequences of OSAS such as cardiovascular disease, glucose intolerance and fatigue. Scientific studies have shown that vigorous physical activity is associated with a decrease in the prevalence of OSAS, improved sleep efficiency and the Epworth Sleepiness Scale.
Moreover, recent evidence has shown that oropharyngeal exercises can be useful in the treatment of OSAS decreasing neck circumference, snoring, subjective sleepiness and AHI as well as improving the quality of life and saturation oxygen.
The 60-70% of patients with OSAS is overweight or obese showing that a high body mass index (BMI) is an independent risk factor for the occurrence of OSAS. Many studies have shown that weight loss is associated with significant reduction in AHI.
However, despite the scientific evidence to justify the inclusion of these modalities, there is no study that has analyzed the impact of performing together all these interventions. It is expected that the combination can produce a cumulative effect that impacts significantly on improving indicators of OSAS.
The investigators will include patients with a recent diagnosis of moderate or severe OSA. Patients will be randomized to interventional or control group.
Patients included in the study will be followed for almost three months and they will be examined at baseline and after time of follow-up or intervention.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Interventional group
Participants followed a 8-week intervention program with a total of 24 sessions (12 of those were supervised). The aim of the supervision was to increase the adherence to the treatment and to control the compliance of patients. General physical activity consisted in walking along previously standardized urban parks designed for the urban EPOC training project (Arbillaga-Etxarri et al, 2016). The duration of walking were 30 minutes. The physiotherapist supervised the accomplishment of other activities such as oropharyngeal exercises and diet control.
Oropharyngeal exercises:
1. Expiratory muscle strength training (EMST):
2. Masako Manoeuvre
3. Shaker Head Lift:
4. Facial exercise
Exercise
Walking in community Oropharyngeal exercises Diet recommendations Dietary recommendations Education
Control Group
Control group participants only received general recommendations regarding general physical activity, diet and sleep hygiene. After 8-weeks of control, they were re-evaluated with the same evaluation test used in the beginning of the study period. Recommendations for general physical activity were walking during 30 minutes at least 3 times a week maintaining the greatest possible pace. Also, control group patients received the same diet control document as intervention group and verbal advice for sleep hygiene. Approximately 1 month after enrolment, a follow-up phone call was completed were we also informed about the new re-evaluation data.
Control
Dietary and general recommendations
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Exercise
Walking in community Oropharyngeal exercises Diet recommendations Dietary recommendations Education
Control
Dietary and general recommendations
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Concomitant heart disease, stroke or severe neuromuscular with medical judgment not doing exercise.
* Musculoskeletal disorders that impede the realization of the exercises
* Sleepiness affects your physical or occupational functioning.
20 Years
85 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hospital Clinic of Barcelona
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Jose M. Montserrat
MD
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Rodrigo Torres, MSc
Role: PRINCIPAL_INVESTIGATOR
University of Barcelona
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hospital Clinic de Barcelona
Barcelona, Catalonia, Spain
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SEPAR-ALAT-2014
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.